Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Allergan plc (AGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/21/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
05/19/2020 EFFECT Form EFFECT - Notice of Effectiveness:
05/19/2020 EFFECT Form EFFECT - Notice of Effectiveness:
05/19/2020 EFFECT Form EFFECT - Notice of Effectiveness:
05/19/2020 EFFECT Form EFFECT - Notice of Effectiveness:
05/14/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/14/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/14/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/14/2020 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
05/14/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 8-K Quarterly results
05/11/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
05/08/2020 8-K Quarterly results
05/07/2020 10-Q Quarterly Report for the period ended March 31, 2020
05/06/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Announcement relating to the outcome of the Court Sanction Hearing"
04/29/2020 10-K/A Annual Report for the period ended December 31, 2019 [amend]
04/21/2020 8-K Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Other Events, Financial Statements and Exhibits ...
Docs: "FORM 8-K",
"Blackout Notice, provided to directors and Section 16 officers of Allergan"
03/03/2020 8-K Quarterly results
02/18/2020 10-K Annual Report for the period ended December 31, 2019
02/13/2020 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2020 8-K Quarterly results
01/27/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep"
11/05/2019 10-Q Quarterly Report for the period ended September 30, 2019
11/05/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Investor FAQ"
11/05/2019 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy